Two-year clinical outcome from the Iberian registry patients after left atrial appendage closure
Conclusions
LAA closure with an occlusion device in patients contraindicated for oral anticoagulants is a therapeutic option associated with fewer thromboembolic and haemorrhagic events than expected from risk scores, particularly in the second year postimplantation.
Source: Heart - Category: Cardiology Authors: Minguez, J. R. L., Asensio, J. M. N., Gragera, J. E., Costa, M., Gonzalez, I. C., de Carlos, F. G., Diaz, J. A. F., Yuste, V. M., Gonzalez, R. M., Dominguez-Franco, A., Buendia, A. B., Garibi, J. H., Hernandez, F. H., Ribeiro, V. G. Tags: Congenital heart disease in adult patients, Editor's choice, Drugs: cardiovascular system, Heart failure, Hypertension, Epidemiology Arrhythmias and sudden death Source Type: research
More News: Alcoholism | Arrhythmia | Aspirin | Atrial Fibrillation | Bleeding | Cardiology | Cardiovascular | Clopidogrel | Congestive Heart Failure | Diabetes | Endocrinology | Epidemiology | Heart | Heart Disease | Heart Failure | Hemorrhagic Stroke | Hypertension | Ischemic Stroke | Liver | Plavix | Stroke | Study | Urology & Nephrology